ArticleJAC-antimicrobial resistance2026
Oritavancin as consolidation or suppressive therapy in infective endocarditis and device-related infections: real-world experience with therapeutic drug monitoring.
Simone Giuliano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.